Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) saw a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 17,400 shares, a decline of 6.5% from the August 31st total of 18,600 shares. Based on an average trading volume of 20,500 shares, the days-to-cover ratio is currently 0.8 days.

Apollomics Stock Performance

Apollomics stock opened at $0.01 on Wednesday. Apollomics has a 1 year low of $0.01 and a 1 year high of $0.10. The company’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.02.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.